HIGH-RISK PROSTATE CANCER
Clinical trials for HIGH-RISK PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new HIGH-RISK PROSTATE CANCER trials appear
Sign up with your email to follow new studies for HIGH-RISK PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can Pre-Surgery hormone cocktail boost erection recovery in prostate cancer?
Disease control OngoingThis phase 2 trial tests whether giving hormone therapy before prostate surgery helps men with high-risk prostate cancer recover erectile function better. About 90 men will receive either apalutamide alone or a combination of apalutamide, abiraterone, GnRH agonist, and prednisone…
Matched conditions: HIGH-RISK PROSTATE CANCER
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jul 02, 2026 04:00 UTC
-
New immunotherapy combo targets High-Risk prostate cancer before and after surgery
Disease control TerminatedThis study was designed for men with high-risk prostate cancer who are scheduled for prostate removal surgery. It planned to give a combination of three immunotherapy drugs (N-803, ETBX-071, and M-CENK) both before and after surgery to see if it could help prevent the cancer from…
Matched conditions: HIGH-RISK PROSTATE CANCER
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Promising prostate cancer combo trial pulled before starting
Disease control TerminatedThis study was designed for men with high-risk prostate cancer who cannot have surgery. It planned to combine three experimental drugs (N-803, ETBX-071, and M-CENK) with radiation to boost the immune system's attack on cancer. Researchers aimed to see if the treatment could elimi…
Matched conditions: HIGH-RISK PROSTATE CANCER
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Radiation before surgery shows promise for aggressive prostate cancer
Disease control OngoingThis study tests whether giving a precise, high-dose radiation treatment (SBRT) before prostate removal surgery is safe and effective for men with high-risk prostate cancer. Sixteen men with aggressive prostate cancer (Gleason score 8 or higher or signs of spread) will receive ra…
Matched conditions: HIGH-RISK PROSTATE CANCER
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Fish oil pills could help fight prostate cancer, new study hints
Disease control OngoingThis phase 2 trial tests whether taking omega-3 (EPA) supplements can reduce inflammation and slow cancer cell growth in men with high-risk prostate cancer who choose surgery. 130 participants will take either EPA capsules or a placebo for 14 months, starting before surgery. Rese…
Matched conditions: HIGH-RISK PROSTATE CANCER
Phase: PHASE2 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Double scan strategy could sharpen prostate cancer staging
Diagnosis OngoingThis study looks at whether combining PSMA-PET/CT and MRI scans can more accurately determine the extent of prostate cancer in men with intermediate- or high-risk disease. Researchers will compare scan results with tissue samples from 600 men who had their prostate removed. The g…
Matched conditions: HIGH-RISK PROSTATE CANCER
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
New study aims to predict prostate cancer treatment success early
Knowledge-focused OngoingThis pilot study looks at whether special scans (PSMA PET/MRI) and genetic tests can predict how well high-risk prostate cancer responds to hormone therapy and radiation. Thirty participants will be followed for up to 5 years. The goal is to find markers that identify poor respon…
Matched conditions: HIGH-RISK PROSTATE CANCER
Phase: EARLY_PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New scan could reveal hidden cancer in High-Risk prostate patients
Knowledge-focused OngoingThis study involves 400 men with high-risk prostate cancer who have not yet received treatment. Researchers are using a special type of scan called PSMA PET to see if it can find cancer that has spread to lymph nodes or other parts of the body, which standard scans often miss. Th…
Matched conditions: HIGH-RISK PROSTATE CANCER
Sponsor: General University Hospital, Prague • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC